细胞治疗心力衰竭的试验和苦难:关于正在进行的试验的最新情况
Jianyi Jay Zhang1,2, Steven M Pogwizd3, Keiichi Fukuda4
1Department of Biomedical Engineering, School of Medicine, School of Engineering, The University of Alabama at Birmingham, Birmingham, AL, USA. jayzhang@uab.edu.
Nature reviews. Cardiology
|November 15, 2024
概括
细胞疗法通过再生受损的心肌,为心力衰竭 (HF) 治疗提供了一种有前途的方法. 目前正在进行的试验正在评估安全性,疗效,以及推进心脏修复的新方案.
科学领域:
- 心脏病学 心脏病学
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 心力衰竭 (HF) 是全球死亡的主要原因之一,预后不佳.
- 失去了心肌细胞和有限的心脏再生在治疗缺血性高血压时带来了重大挑战.
- 目前对不可逆转的心脏损伤的治疗依赖于心脏移植.
研究的目的:
- 审查正在进行的基于细胞和基于细胞产品的治疗心力衰竭的临床试验.
- 评估用于心脏修复和再生的细胞治疗的进展和挑战.
- 确定心脏再生疗法的临床转化关键因素.
主要方法:
- 目前临床试验的概述 在细胞治疗中对HF.
- 基于细胞的治疗药物的安全性和疗效的评估.
- 探索新的治疗方案,包括剂量,输送和患者选择.
主要成果:
- 细胞疗法已经发展成为心脏修复的有希望的策略.
- 在临床前和临床研究中遇到了实质性的障碍,但正在解决.
- 目前正在进行的试验正在调查细胞治疗的各种方面,以治疗HF.
结论:
- 目前正在进行的试验的结果对于心脏再生疗法的临床转化至关重要.
- 评估安全性,疗效和新方案将推动HF细胞治疗领域的发展.
- 该领域通过从过去的研究中学习和探索新的治疗策略,继续取得进展.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


